Literature DB >> 14668704

Epidemiology of contrast-induced nephropathy.

Peter A McCullough1, Keisha R Sandberg.   

Abstract

Decreasing levels of renal function act as a major adverse prognostic factor after contrast exposure with or without percutaneous coronary intervention. In chronic kidney disease, the most important risk factor for the development of contrast-induced nephropathy (CIN) is an estimated glomerular filtration rate </= 60 mL/min/1.73 m2. Additional risk factors include diabetes, proteinuria, volume depletion, heart failure, and intraprocedural events. Overall, CIN occurs in approximately 15% of radiocontrast procedures, with < 1% requiring dialysis. CIN is directly related to increases in hospitalization length, cost, and long-term morbidity. For those patients who require dialysis, a 30% in-hospital mortality rate and 80% 2-year mortality rate can be expected. CIN is predictable and presents an opportunity to utilize preventive strategies, given the increasing numbers of patients undergoing contrast procedures worldwide.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14668704

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  42 in total

1.  Effects of hydration combined with Shenfu injection on contrast-induced acute kidney injury in acute coronary syndrome patients undergoing percutaneous coronary intervention.

Authors:  Zhen Guo; Dandan Niu; Yaren Yu; Di Zhen; Wenhua Li
Journal:  Biomed Rep       Date:  2017-09-22

2.  Ultra-low dose contrast CT pulmonary angiography in oncology patients using a high-pitch helical dual-source technology.

Authors:  Prabhakar Rajiah; Leslie Ciancibello; Ronald Novak; Jennifer Sposato; Luis Landeras; Robert Gilkeson
Journal:  Diagn Interv Radiol       Date:  2019-05       Impact factor: 2.630

3.  Changing Paradigms in Contrast Nephropathy.

Authors:  Arnaldo Lopez-Ruiz; Kiran Chandrashekar; Luis A Juncos
Journal:  J Am Soc Nephrol       Date:  2017-01-19       Impact factor: 10.121

4.  Evaluation of a handheld creatinine measurement device for real-time determination of serum creatinine in radiology departments.

Authors:  Stefan Haneder; Alexandra Gutfleisch; Claudia Meier; Joachim Brade; Dieter Hannak; Stefan O Schoenberg; Christoph R Becker; Henrik J Michaely
Journal:  World J Radiol       Date:  2012-07-28

Review 5.  Validation of a tool predicting important findings on computed tomography among Crohn's disease patients.

Authors:  Shail M Govani; Akbar K Waljee; Keith E Kocher; Jason M Swoger; Melissa Saul; Peter Dr Higgins
Journal:  United European Gastroenterol J       Date:  2016-07-08       Impact factor: 4.623

6.  Early diagnosis of acute kidney injury in aged patients undergoing percutaneous coronary intervention.

Authors:  Hong-Hua Ye; Gen Shen; Qun Luo; Fang-Fang Zhou; Xiao-Ling Xie; Chun-Yan Wang; Li-Na Han
Journal:  J Zhejiang Univ Sci B       Date:  2018-05       Impact factor: 3.066

Review 7.  Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.

Authors:  Fulvio Stacul; Aart J van der Molen; Peter Reimer; Judith A W Webb; Henrik S Thomsen; Sameh K Morcos; Torsten Almén; Peter Aspelin; Marie-France Bellin; Olivier Clement; Gertraud Heinz-Peer
Journal:  Eur Radiol       Date:  2011-08-25       Impact factor: 5.315

Review 8.  Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology.

Authors:  Stanley Goldfarb; Peter A McCullough; John McDermott; Spencer B Gay
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

9.  Prevention of contrast-induced nephropathy with prostaglandin E1 in high-risk patients undergoing percutaneous coronary intervention.

Authors:  Wen-Hua Li; Dong-Ye Li; Wen-Hao Qian; Jia-Li Liu; Tong-Da Xu; Hong Zhu; Hai-Yan He
Journal:  Int Urol Nephrol       Date:  2014-02-26       Impact factor: 2.370

Review 10.  Preventing contrast-induced nephropathy: problems, challenges and future directions.

Authors:  Richard Solomon
Journal:  BMC Med       Date:  2009-05-13       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.